Association of serum intact parathyroid hormone with lower estimated glomerular filtration rate

Clinical Journal of the American Society of Nephrology

Volumn 4, Issue 1, 2009, Pages 186-194

  Muntner, Paul ^a   Jones, Tiffany M ^b   Hyre, Amanda D ^c   Melamed, Michal L ^d   Alper, Arnold ^b   Raggi, Paolo ^e   Leonard, Mary B ^c,f  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; PARATHYROID HORMONE; VITAMIN D; BIOLOGICAL MARKER; HYDROXYCOLECALCIFEROL; PHOSPHORUS;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CALCIUM BLOOD LEVEL; CALCIUM INTAKE; CALORIC INTAKE; CHRONIC KIDNEY DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DIET SUPPLEMENTATION; DISEASE SEVERITY; ETHNICITY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; METABOLIC BONE DISEASE; PARATHYROID HORMONE BLOOD LEVEL; PREVALENCE; RACE; BIOLOGICAL MODEL; BLOOD; CHRONIC DISEASE; CROSS-SECTIONAL STUDY; ETHNOLOGY; HEALTH SURVEY; HOSPITALIZATION; KIDNEY; KIDNEY DISEASE; MIDDLE AGED; NUTRITION; PATHOPHYSIOLOGY; UNITED STATES; UPREGULATION;

ADULT; AGED; BIOLOGICAL MARKERS; CALCIUM; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HEALTH SURVEYS; HUMANS; HYDROXYCHOLECALCIFEROLS; KIDNEY; KIDNEY DISEASES; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; NUTRITION SURVEYS; PARATHYROID HORMONE; PHOSPHORUS; SEVERITY OF ILLNESS INDEX; UNITED STATES; UP-REGULATION;

EID: 64049085963     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.03050608     Document Type: Article

References (48)

1. Danese MD, Kim J, Doan QV, Dylan M, Griffiths R, Chertow GM: PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis. Am J Kidney Dis 47: 149-156, 2006 (Pubitemid 41828277)
2. Gallieni M, Cucciniello E, D'Amaro E, Fatuzzo P, Gaggiotti A, Maringhini S, Rotolo U, Brancaccio D: Calcium, phosphate, and PTH levels in the hemodialysis population: A multicenter study. J Nephrol 15: 165-170, 2002 (Pubitemid 34594167)
3. Torres A, Lorenzo V, Hernandez D, Rodriguez JC, Concepcion MT, Rodriguez AP, Hernandez A, de Bonis E, Darias E, Gonzalez-Posada JM: Bone disease in predialysis, hemodialysis, and CAPD patients: Evidence of a better bone response to PTH. Kidney Int 47: 1434-1442, 1995
4. Coburn JW, Elangovan L: Prevention of metabolic bone disease in the pre-end-stage renal disease setting. J Am Soc Nephrol 9: S71-S77, 1998
5. Llach F, Massry SG, Singer FR, Kurokawa K, Kaye JH, Coburn JW: Skeletal resistance to endogenous parathyroid hormone in pateints with early renal failure. A possible cause for secondary hyperparathyroidism. J Clin Endocrinol Metab 41: 339-345, 1975
6. Fajtova VT, Sayegh MH, Hickey N, Aliabadi P, Lazarus JM, LeBoff MS: Intact parathyroid hormone levels in renal insufficiency. Calcif Tissue Int 57: 329-335, 1995
7. Brossard JH, Cloutier M, Roy L, Lepage R, Gascon-Barre M, D'Amour P: Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: Importance in the interpretation of PTH values. J Clin Endocrinol Metab 81: 3923-3929, 1996 (Pubitemid 26380397)
8. Rix M, Andreassen H, Eskildsen P, Langdahl B, Olgaard K: Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure. Kidney Int 56: 1084-1093, 1999 (Pubitemid 29411737)
9. Martinez I, Saracho R, Montenegro J, Llach F: The importance of dietary calcium and phosphorous in the secondary hyperparathyroidism of patients with early renal failure. Am J Kidney Dis 29: 496-502, 1997 (Pubitemid 27155269)
10. Coen G, Mazzaferro S, Ballanti P, Sardella D, Chicca S, Manni M, Bonucci E, Taggi F: Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure: A cross-sectional study. Nephrol Dial Transplant 11: 813-819, 1996 (Pubitemid 26148251)
11. Fried LF, Biggs L, Shlipak MG, Seliger S, Kestenbaum B, Stehman-Breen C, Sarnak M, Siscovick D, Harris T, Cauley J, Newman AB, Robbins J: Association of kidney function with incidence hip fracture in older adults. J Am Soc Nephrol 18: 282-286, 2007 (Pubitemid 46053440)
12. Nickolas TL, McMahon DJ, Shane E: Relationship between moderate to severe kidney disease and hip fracture in the United States. J Am Soc Nephrol 17: 3223-3232, 2006
13. National Kidney Foundation: K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42:S1-201, 2003
14. Gretz N, Giovanetti S, Barsotti G, Schmicker R, Rosman G: Influence of dietary treatment on the rate of progression of chronic renal failure. In: Nutritional Treatment of Chronic Renal Failure, edited by Giovanetti S, Boston MA, Kluwer, 1989, pp 211-229
15. Barsotti G, Cupisti A, Ciardella F, Morelli E, Niosi F, Giovannetti S: Compliance with protein restriction: Effects on metabolic acidosis and progression of renal failure in chronic uremics on supplemented diet. Contrib Nephrol 81: 42-49, 1990
16. Andress DL: Vitamin D treatment in chronic kidney disease. Semin Dial 18: 315-321, 2005 (Pubitemid 41166535)
17. Hernandez JD, Wesseling K, Salusky IB: Role of parathyroid hormone and therapy with active vitamin D sterols in renal osteodystrophy. Semin Dial 18: 290-295, 2005 (Pubitemid 41159578)
18. Cunningham J, Sprague SM, Cannata-Andia J, Coco M, Cohen-Solal M, Fitzpatrick L, Goltzmann D, Lafage-Proust MH, Leonard M, Ott S, Rodriguez M, Stehman-Breen C, Stern P, Weisinger J: Osteoporosis in chronic kidney disease. Am J Kidney Dis 43: 566-571, 2004
19. Malluche HH, Langub MC, Monier-Faugere MC: Pathogenesis and histology of renal osteodystrophy. Osteoporos Int 7 [Suppl 3]: S184-S187, 1997
20. National Center for Health Statistics. NHANES 2003-2004. http://www.cdc.gov/nchs/about/major/nhanes/nhanes2003-2004/nhanes03-04.htm. Accessed 9-1-2006
21. Souberbielle JC, Boutten A, Carlier MC, Chevenne D, Coumaros G, Lawson-Body E, Massart C, Monge M, Myara J, Parent X, Plouvier E, Houillier P: Inter-method variability in PTH measurement: Implication for the care of CKD patients. Kidney Int 70: 345-350, 2006 (Pubitemid 44086584)
22. Hollis BW, Kamerud JQ, Selvaag SR, Lorenz JD, Napoli JL: Determination of vitamin D status by radioimmunoassay with an 125I-labeled tracer. Clin Chem 39: 529-533, 1993 (Pubitemid 23099026)
23. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G: National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med 139: 137-147, 2003 (Pubitemid 38129105)
24. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van LF, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA 298: 2038-2047, 2007 (Pubitemid 350074801)
25. Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, Andress DL: Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 71: 31-38, 2007 (Pubitemid 44967731)
26. Gutierrez OM, Isakova T, Andress DL, Levin A, Wolf M: Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney disease. Kidney Int 73: 956-962, 2008
27. Kant AK, Graubard BI, Kumanyika SK: Trends in black-white differentials in dietary intakes of U.S. adults, 1971-2002. Am J Prev Med 32: 264-272, 2007
28. az-Gomez NM, Mendoza C, Gonzalez-Gonzalez NL, Barroso F, Jimenez-Sosa A, Domenech E, Clemente I, Barrios Y, Moya M: Maternal smoking and the vitamin D-parathyroid hormone system during the perinatal period. J Pediatr 151: 618-623, 2007
29. Jorde R, Saleh F, Figenschau Y, Kamycheva E, Haug E, Sundsfjord J: Serum parathyroid hormone (PTH) levels in smokers and non-smokers. The fifth Tromso study. Eur J Endocrinol 152: 39-45, 2005 (Pubitemid 40185451)
30. Need AG, Kemp A, Giles N, Morris HA, Horowitz M, Nordin BE: Relationships between intestinal calcium absorption, serum vitamin D metabolites and smoking in postmenopausal women. Osteoporos Int 13: 83-88, 2002 (Pubitemid 34157835)
31. Laitinen K, Lamberg-Allardt C, Tunninen R, Karonen SL, Tahtela R, Ylikahri R, Valimaki M: Transient hypoparathyroidism during acute alcohol intoxication. N Engl J Med 324: 721-727, 1991
32. Perry HM, III, Horowitz M, Fleming S, Kaiser FE, Patrick P, Morley JE, Cushman W, Bingham S, Perry HM, Jr.: Effect of recent alcohol intake on parathyroid hormone and mineral metabolism in men. Alcohol Clin Exp Res 22:1369-1375, 1998 (Pubitemid 28443163)
33. Rico H, Cabranes JA, Cabello J, Gomez-Castresana F, Hernandez ER: Low serum osteocalcin in acute alcohol intoxication: A direct toxic effect of alcohol on osteoblasts. Bone Miner 2: 221-225, 1987 (Pubitemid 17115614)
34. Malabanan A, Veronikis IE, Holick MF: Redefining vitamin D insufficiency. Lancet 351: 805-806, 1998
35. Clemens TL, Adams JS, Henderson SL, Holick MF: Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. Lancet 1: 74-76, 1982
36. Parikh SJ, Edelman M, Uwaifo GI, Freedman RJ, Semega-Janneh M, Reynolds J, Yanovski JA: The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab 89: 1196-1199, 2004 (Pubitemid 38368412)
37. Looker AC: Body fat and vitamin D status in black versus white women. J Clin Endocrinol Metab 90: 635-640, 2005
38. Snijder MB, van Dam RM, Visser M, Deeg DJ, Dekker JM, Bouter LM, Seidell JC, Lips P: Adiposity in relation to vitamin D status and parathyroid hormone levels: A population-based study in older men and women. J Clin Endocrinol Metab 90: 4119-4123, 2005 (Pubitemid 41058184)
39. Schluter KD, Piper HM: Trophic effects of catecholamines and parathyroid hormone on adult ventricular cardiomyocytes. Am J Physiol 263: H1739-H1746, 1992
40. Amann K, Ritz E, Wiest G, Klaus G, Mall G: A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia. J Am Soc Nephrol 4: 1814-1819, 1994
41. Horl WH: The clinical consequences of secondary hyperparathyroidism: Focus on clinical outcomes. Nephrol Dial Transplant 19 [Suppl 5]: V2-V8, 2004 (Pubitemid 39214193)
42. Goodman WG: The consequences of uncontrolled secondary hyperparathyroidism and its treatment in chronic kidney disease. Semin Dial 17: 209-216, 2004
43. Schulz E, Arfai K, Liu X, Sayre J, Gilsanz V: Aortic calcification and the risk of osteoporosis and fractures. J Clin Endocrinol Metab 89: 4246-4253, 2004 (Pubitemid 39244420)
44. Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft FC: Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 27: 394-401, 1996 (Pubitemid 26075849)
45. London GM, Marty C, Marchais SJ, Guerin AP, Metivier F, de Vernejoul MC: Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol 15: 1943-1951, 2004
46. Hsu CY, Chertow GM: Elevations of serum phosphorus and potassium in mild to moderate chronic renal insufficiency. Nephrol Dial Transplant 17: 1419-1425, 2002 (Pubitemid 34893282)
47. Pitts TO, Piraino BH, Mitro R, Chen TC, Segre GV, Greenberg A, Puschett JB: Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure. J Clin Endocrinol Metab 67: 876-881, 1988 (Pubitemid 18277204)
48. Schomig M, Ritz E: Management of disturbed calcium metabolism in uraemic patients: 1. Use of vitamin D metabolites. Nephrol Dial Transplant 15 [Suppl 5]: 18-24, 2000 (Pubitemid 30784387)